Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor
PurposeTo develop and validate nomograms for pre-treatment prediction of malignant histology (MH) and unfavorable pathology (UP) in patients with endophytic renal tumors (ERTs).MethodsWe retrospectively reviewed the clinical information of 3245 patients with ERTs accepted surgical treatment in our c...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.964048/full |
_version_ | 1798031795213565952 |
---|---|
author | Xinxi Deng Xinxi Deng Xiaoqiang Liu Xiaoqiang Liu Bing Hu Bing Hu Ming Jiang Ming Jiang Ke Zhu Ke Zhu Jianqiang Nie Jianqiang Nie Taobin Liu Taobin Liu Luyao Chen Luyao Chen Wen Deng Wen Deng Bin Fu Bin Fu Situ Xiong Situ Xiong |
author_facet | Xinxi Deng Xinxi Deng Xiaoqiang Liu Xiaoqiang Liu Bing Hu Bing Hu Ming Jiang Ming Jiang Ke Zhu Ke Zhu Jianqiang Nie Jianqiang Nie Taobin Liu Taobin Liu Luyao Chen Luyao Chen Wen Deng Wen Deng Bin Fu Bin Fu Situ Xiong Situ Xiong |
author_sort | Xinxi Deng |
collection | DOAJ |
description | PurposeTo develop and validate nomograms for pre-treatment prediction of malignant histology (MH) and unfavorable pathology (UP) in patients with endophytic renal tumors (ERTs).MethodsWe retrospectively reviewed the clinical information of 3245 patients with ERTs accepted surgical treatment in our center. Eventually, 333 eligible patients were included and randomly enrolled into training and testing sets in a ratio of 7:3. We performed univariable and multivariable logistic regression analyses to determine the independent risk factors of MH and UP in the training set and developed the pathological diagnostic models of MH and UP. The optimal model was used to construct a nomogram for MH and UP. The area under the receiver operating characteristics (ROC) curves (AUC), calibration curves and decision curve analyses (DCA) were used to evaluate the predictive performance of models.ResultsOverall, 172 patients with MH and 50 patients with UP were enrolled in the training set; and 74 patients with MH and 21 patients with UP were enrolled in the validation set. Sex, neutrophil-to-lymphocyte ratio (NLR), R score, N score and R.E.N.A.L. score were the independent predictors of MH; and BMI, NLR, tumor size and R score were the independent predictors of UP. Single-variable and multiple-variable models were constructed based on these independent predictors. Among these predictive models, the malignant histology-risk nomogram consisted of sex, NLR, R score and N score and the unfavorable pathology-risk nomogram consisted of BMI, NLR and R score performed an optimal predictive performance, which reflected in the highest AUC (0.842 and 0.808, respectively), the favorable calibration curves and the best clinical net benefit. In addition, if demographic characteristics and laboratory tests were excluded from the nomograms, only the components of the R.E.N.A.L. Nephrometry Score system were included to predict MH and UP, the AUC decreased to 0.781 and 0.660, respectively (P=0.001 and 0.013, respectively).ConclusionIn our study, the pathological diagnostic models for predicting malignant and aggressive histological features for patients with ERTs showed outstanding predictive performance and convenience. The use of the models can greatly assist urologists in individualizing the management of their patients. |
first_indexed | 2024-04-11T20:03:19Z |
format | Article |
id | doaj.art-30dab687f9704c6db4ea0086a4726763 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-11T20:03:19Z |
publishDate | 2022-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-30dab687f9704c6db4ea0086a47267632022-12-22T04:05:27ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-09-011210.3389/fonc.2022.964048964048Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumorXinxi Deng0Xinxi Deng1Xiaoqiang Liu2Xiaoqiang Liu3Bing Hu4Bing Hu5Ming Jiang6Ming Jiang7Ke Zhu8Ke Zhu9Jianqiang Nie10Jianqiang Nie11Taobin Liu12Taobin Liu13Luyao Chen14Luyao Chen15Wen Deng16Wen Deng17Bin Fu18Bin Fu19Situ Xiong20Situ Xiong21Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Urology, Jiu Jiang NO.1 People’s Hospital, Jiujiang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaJiangxi Institute of Urology, Nanchang, ChinaPurposeTo develop and validate nomograms for pre-treatment prediction of malignant histology (MH) and unfavorable pathology (UP) in patients with endophytic renal tumors (ERTs).MethodsWe retrospectively reviewed the clinical information of 3245 patients with ERTs accepted surgical treatment in our center. Eventually, 333 eligible patients were included and randomly enrolled into training and testing sets in a ratio of 7:3. We performed univariable and multivariable logistic regression analyses to determine the independent risk factors of MH and UP in the training set and developed the pathological diagnostic models of MH and UP. The optimal model was used to construct a nomogram for MH and UP. The area under the receiver operating characteristics (ROC) curves (AUC), calibration curves and decision curve analyses (DCA) were used to evaluate the predictive performance of models.ResultsOverall, 172 patients with MH and 50 patients with UP were enrolled in the training set; and 74 patients with MH and 21 patients with UP were enrolled in the validation set. Sex, neutrophil-to-lymphocyte ratio (NLR), R score, N score and R.E.N.A.L. score were the independent predictors of MH; and BMI, NLR, tumor size and R score were the independent predictors of UP. Single-variable and multiple-variable models were constructed based on these independent predictors. Among these predictive models, the malignant histology-risk nomogram consisted of sex, NLR, R score and N score and the unfavorable pathology-risk nomogram consisted of BMI, NLR and R score performed an optimal predictive performance, which reflected in the highest AUC (0.842 and 0.808, respectively), the favorable calibration curves and the best clinical net benefit. In addition, if demographic characteristics and laboratory tests were excluded from the nomograms, only the components of the R.E.N.A.L. Nephrometry Score system were included to predict MH and UP, the AUC decreased to 0.781 and 0.660, respectively (P=0.001 and 0.013, respectively).ConclusionIn our study, the pathological diagnostic models for predicting malignant and aggressive histological features for patients with ERTs showed outstanding predictive performance and convenience. The use of the models can greatly assist urologists in individualizing the management of their patients.https://www.frontiersin.org/articles/10.3389/fonc.2022.964048/fullendophytic renal tumorpathological featuremalignant histologyunfavorable pathologythe R.E.N.A.L. Nephrometry Scorepathological diagnostic model |
spellingShingle | Xinxi Deng Xinxi Deng Xiaoqiang Liu Xiaoqiang Liu Bing Hu Bing Hu Ming Jiang Ming Jiang Ke Zhu Ke Zhu Jianqiang Nie Jianqiang Nie Taobin Liu Taobin Liu Luyao Chen Luyao Chen Wen Deng Wen Deng Bin Fu Bin Fu Situ Xiong Situ Xiong Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor Frontiers in Oncology endophytic renal tumor pathological feature malignant histology unfavorable pathology the R.E.N.A.L. Nephrometry Score pathological diagnostic model |
title | Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor |
title_full | Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor |
title_fullStr | Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor |
title_full_unstemmed | Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor |
title_short | Pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor |
title_sort | pathological diagnostic nomograms for predicting malignant histology and unfavorable pathology in patients with endophytic renal tumor |
topic | endophytic renal tumor pathological feature malignant histology unfavorable pathology the R.E.N.A.L. Nephrometry Score pathological diagnostic model |
url | https://www.frontiersin.org/articles/10.3389/fonc.2022.964048/full |
work_keys_str_mv | AT xinxideng pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT xinxideng pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT xiaoqiangliu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT xiaoqiangliu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT binghu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT binghu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT mingjiang pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT mingjiang pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT kezhu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT kezhu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT jianqiangnie pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT jianqiangnie pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT taobinliu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT taobinliu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT luyaochen pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT luyaochen pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT wendeng pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT wendeng pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT binfu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT binfu pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT situxiong pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor AT situxiong pathologicaldiagnosticnomogramsforpredictingmalignanthistologyandunfavorablepathologyinpatientswithendophyticrenaltumor |